Search

Your search keyword '"Mullane, Michael"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Mullane, Michael" Remove constraint Author: "Mullane, Michael"
225 results on '"Mullane, Michael"'

Search Results

2. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

4. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

5. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

9. Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

11. Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

13. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3

14. Trends and disparities in colorectal cancer hospitalizations and outcomes: a 10-year joinpoint trend study.

20. Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).

28. Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system.

29. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

32. Abstract P3-14-17: Exploring racial disparities in BRCA testing for triple negative breast cancer patients: A real-world data analysis

33. Numerical Experiments of Counterflowiing Jet Effects on Supersonic Slender-Body Configurations

34. Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.

45. Abstracts of papers and posters safe handling of medicines

46. Basic Trial Advocacy.

47. Bad history, bad policy, and bad law.

49. Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial

Catalog

Books, media, physical & digital resources